Geneuro Innovation SAS

Geneuro Innovation SAS is an SME in Lyon, France that has taken part in 2 EU-funded projects since 2012, receiving €758k in EU funding.

EU funding received€758k
EU projects2
As coordinator0
Running now1
First EU project2012
Latest project2022
CountryFrance
EU registration (PIC)991958085
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Geneuro Innovation SAS's own share of each project, not the project's full budget.

  • Horizon Europe€633k · 1 project
  • FP7 (2007 to 2013)€125k · 1 project

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • HERVCOVPartner

    SARS-CoV-2-induced activation of pathogenic endogenous retrovirus envelope HERV-W: towards personalized treatment of COVID-19 patients

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €633ktheir share
  • PSYCH-AIDPartner

    Advanced Immuno-neuro-endocrine Diagnostics in Psychiatry

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €125ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • immunology
  • laboratory samples analysis
  • proteins
  • schizophrenia

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime